ArticleRSC advances2025
Heat transfer fluids: amino acid anion ionic liquid based IoNanofluids with remarkable thermal conductivity and low viscosity.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Physicochemical Properties and Structural Effects of 1‑Ethyl-4-Alkyl-1,2,4-Triazolium Acetylalaninate Ionic Liquids.ACS omega · 2026Article
- Article
- Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Present study aims to develop ionic liquid based nanofluids (IoNanofluids) exhibiting low viscosity, high thermal conductivity, thermal stability, high specific heat capacity and colloidal stability for potential heat transfer fluids applications. Four amino acid anion ionic liquids (AAIL) such as 1-butyl,3-metylimidazolium glycinate, 1-butyl,3-metylimidazolium arginate, 1-ethyl,3-metylimidazolium glycinate, 1-ethyl,3-metylimidazolium arginate were synthesized. The IoNanofluids (INF) were developed by adding 0.05 wt% of MWCNT to the AAILs. The effect of MWCNT concentration and surfactant was investigated by developing INFs consisting of 1-butyl, 3-methylimidazolium tetrafluoroborate ([bmim]
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.